Higher levels of serum fibrin-monomer reflect hypercoagulable state and thrombus formation in the left atrial appendage in patients with acute ischemic stroke

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 971-976

  Okuyama, Hidenobu ^a   Hirono, Osamu ^a   Liu, Ling ^a   Takeishi, Yasuchika ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Fibrin monomer; Left atrial appendage; Thrombus; Trans esophageal echocardiography

Indexed keywords

BIOCHEMICAL MARKER; FIBRIN; MONOMER;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOLYSIS; FLOW RATE; HEART ATRIUM APPENDAGE; HEART ATRIUM CONTRACTION; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SCREENING; THROMBOEMBOLISM; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; BLOOD FLOW VELOCITY; CEREBROVASCULAR ACCIDENT; CORONARY VESSELS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; THROMBOPHILIA; THROMBOSIS;

EID: 33746771433     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.971     Document Type: Article

References (32)

1. National Institute of Neurological Disorders and Stroke. Special report: Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-676.
2. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: Findings of the national conference on cardiovascular disease prevention. Circulation 2000; 102: 3137-3147.
3. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke: The Framingham study. Stroke 1982; 13: 290-295.
4. Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus. Circulation 1991; 84: 223-231.
5. Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of cardiac source of embolism in stroke patients. Stroke 1991; 22: 727-733.
6. Shinokawa N, Hirai T, Takashima S, Kameyama T, Obata Y, Nakagawa K, et al. Relation of transesophageal echocardiographic findings to subtypes of cerebral infarction in patients with atrial fibrillation. Clin Cardiol 2000; 23: 517-522.
7. Takada T, Yasaka M, Nagatsuka K, Minematsu K, Yamaguchi T. Blood flow in the left atrial appendage and embolic stroke in nonvalvular atrial fibrillation. Eur Neurol 2001; 46: 148-152.
8. Garcia-Fernandez MA, Torrecilla EG, San Roman D, Azevedo J, Bueno H, Moreno MM, et al. Left atrial appendage Doppler flow patterns: Implications on thrombus formation. Am Heart J 1992; 124: 955-961.
9. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. II: Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6-12.
10. Verhorst PM, Kamp O, Visser CA, Verheugt FW. Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism. Am J Cardiol 1993; 71: 192-196.
11. Mugge A, Kuhn H, Nikutta P, Grote J, Lopez JA, Daniel WG. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with non rheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994; 23: 599-607.
12. Abe Y, Asakura T, Sakamoto N, Ishikawa S, Muroi S, Saitoh F, et al. Embolic attack in patients with atrial fibrillation and atrial thrombus depends on the character of the thrombus. Circ J 2005; 69: 246-248.
13. Sparks PB, Mond HG, Vohra JK, Yapanis AG, Grigg LE, Kalman JM. Mechanical remodeling of the left atrium after loss of atrioventricular synchrony: A long-term study in humans. Circulation 1999; 100: 1714-1721.
14. Blomback B, Bark N. Fibrinopeptide and fibrin gel structure. Biophys Chem 2004; 112: 147-151.
15. Dempfle CE. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state. Thromb Haemost 1999; 82: 673-683.
16. Hong M, Wei W, Li H, Yang R, Yang Y. Association of fibrin monomer polymerization function, cerebrovascular risk factors and ischemic cerebrovascular disease in old people. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 131-133.
17. Deguchi K, Deguchi A, Wada H, Murashima S. Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons. Semin Thromb Hemost 2000; 26: 23-27.
18. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000; 31: 2049-2054.
19. Bamford J, Sanderock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
20. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989; 20: 864-870.
21. Blum A, Reisner S, Farbstein Y. Transesophageal echocardiography (TEE) vs transthoracic echocardiography (TTE) in assessing cardiovascular sources of emboli in patients with acute ischemic stroke. Med Sci Monit 2004; 10: 521-523.
22. Narumiya T, Sakamaki T, Sato Y, Kanmatsuse K. Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter. Circ J 2003; 67: 68-72.
23. Oyama R, Murata K, Tanaka N, Takaki A, Ueda K, Liu J, et al. Is the ratio of transmitral peak E-wave velocity to color flow propagation velocity useful for evaluating the severity of heart failure in atrial fibrillation? Circ J 2004; 68: 132-138.
24. Fatkin D, Feneley MP. Patterns of Doppler-measured blood flow velocity in the normal and fibrillating human left atrial appendage. Am Heart J 1996; 132: 995-1003.
25. Hamano A, Umeda M, Ueno Y, Tanaka S, Mimuro J, Sakata Y. Latex immunoturbidimetric assay for soluble fibrin complex. Clin Chem 2005; 51: 183-188.
26. Gonzalez-Torrecilla E, Garcia-Fernandez MA. Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. Am J Cardiol 2000; 86: 529-534.
27. Kamiyama N, Koyama Y, Suetsuna R, Saito Y, Kaji S, Akasaka T, et al. Decreased left atrial appendage flow velocity with atrial fibrillation caused by negative inotropic agents. Circ J 2003; 67: 277-278.
28. Takano K, Yamaguchi T, Kato H, Omae T. Activation of coagulation in acute cardioembolic stroke. Stroke 1991; 22: 12-16.
29. Takano K, Yamaguchi T, Uchida K. Markers of a hypercoagulable state following acute ischemic stroke. Stroke 1992; 23: 194-198.
30. Sen S, Lima JA, Oppenheimer SM. Changes in cardiac thrombus status after cerebral ischemia. Cerebrovasc Dis 2004; 17: 175-181.
31. Sorescu D, Turk RJ, Cain M, Lerakis S. Clinical and transthoracic echocardiographic predictors of abnormal transesophageal findings in patients with suspected cardiac source of embolism. Am J Med Sci 2003; 326: 31-34.
32. Nozawa T, Inoue H, Izawa A, Okumura K, Jong-dae L, Shimizu A, et al. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Circ J 2004; 68: 29-34.